Vertex Pharmaceuticals Inc (VRTX): Cash & Equivalents
$5.08B
As of 2025-12-31
$6.14B
As of 2026-06-30
-21.5%
3-year compound annual growth
-3.2%
5-year compound annual growth
+21.7%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.08B | +11.3% | 2026-02-13, Balance as of period end |
| 2024-12-31 | $4.57B | -55.9% | 2026-02-13, Balance as of period end |
| 2023-12-31 | $10.37B | -1.3% | 2026-02-13, Balance as of period end |
| 2022-12-31 | $10.50B | +54.6% | 2025-02-13, Balance as of period end |
| 2021-12-31 | $6.79B | +13.5% | 2024-02-15, Balance as of period end |
| 2020-12-31 | $5.99B | +92.6% | 2023-02-10, Balance as of period end |
| 2019-12-31 | $3.11B | +17.3% | 2022-02-09, Balance as of period end |
| 2018-12-31 | $2.65B | +59.1% | 2021-02-11, Balance as of period end |
| 2017-12-31 | $1.67B | +40.7% | 2020-02-13, Balance as of period end |
| 2016-12-31 | $1.18B | +65.6% | 2019-02-13, Balance as of period end |
| 2015-12-31 | $714.77M | +14.3% | 2018-02-15, Balance as of period end |
| 2014-12-31 | $625.26M | +9.8% | 2017-02-23, Balance as of period end |
| 2013-12-31 | $569.30M | +16.3% | 2016-02-16, Balance as of period end |
| 2012-12-31 | $489.41M | +3.0% | 2015-02-13, Balance as of period end |
| 2011-12-31 | $475.32M | +95.4% | 2014-02-11, Balance as of period end |
| 2010-12-31 | $243.20M | -45.6% | 2013-03-01, Balance as of period end |
| 2009-12-31 | $446.66M | +14.8% | 2012-02-22, Balance as of period end |
| 2008-12-31 | $389.12M | n/a | 2011-02-17, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $5.08B | +11.3% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $1.31B | +10.8% |
| Viatris Inc (VTRS) | 2025-12-31 | $1.32B | +80.0% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $3.12B | +25.3% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $3.56B | +7.8% |
| Organon & Co. (OGN) | 2025-12-31 | $574.00M | -15.0% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $4.55B | +73.1% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $545.00M | +16.5% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $1.39B | -42.3% |
Compare VRTX, BHC, VTRS, REGN side by side · Screen every company in Pharmaceutical Preparations ↗